BioDrain Medical, Inc. Hires Director of Sales

MINNEAPOLIS, June 6, 2011 /PRNewswire/ -- BioDrain Medical, Inc. (OTC Bulletin Board: BIOR), producer of the FDA cleared Streamway® System for automated surgical fluid disposal, announced today that the company has hired William Spence as Director of Sales.

As the Company begins its commercial outreach, Mr. Spence will be in charge of marketing BioDrain Medical's innovative patented Streamway System to hospitals, major medical centers and ambulatory surgical centers throughout the U.S.  The Streamway System has received strong positive endorsements from facilities where it has been installed and tested during the Company's product launch phase.   Medical personnel have praised its easy, effective and economical means for safely and automatically disposing of potentially infectious fluids in operating rooms.  Hazardous waste disposal costs have been lowered, supply costs have been reduced, and the safety of staff and patients has been improved.

Mr. Spence has over eight years experience in business development in the medical industry, focused on the sales and marketing of capital equipment and consumable supplies.  Mr. Spence started his own medical distribution company that assisted manufacturers in expanding their current product lines and bringing new technologies to the market.  In this role, he expanded his company's reach to 14 states and negotiated its acquisition by a larger company.

Kevin Davidson, CEO of BioDrain, said, "We are very pleased to have Bill Spence join the BioDrain team.  Bill has an intimate understanding of the medical industry and feels the excitement of introducing our Streamway System to medical facilities that are eager to experience its safety and cost-reducing benefits.  He will provide important leadership for our product launch to multiple types of facilities in a complex, multi-state market."

About BioDrain Medical, Inc.

BioDrain Medical, Inc. has a fully automated, patented, FDA cleared, surgical fluid management system that virtually eliminates operating room workers' exposure to blood, irrigation fluid and the related germs, viruses and diseases that are potentially found in the surgical environment.  Today's manual surgical fluid handling methods of hand-carrying filled surgical fluid canisters and emptying these canisters is an exposure risk and an antiquated approach to the handling of surgical fluid waste.  BioDrain's Streamway system fully automates the collection, measurement and disposal of surgical fluids resulting in: 1) reducing overhead costs to hospitals and surgical centers, 2) improving the Occupational State and Health Association (OSHA) and other regulatory compliance, and 3) improving the efficiency of the operating room (and thereby making surgeries more profitable).

BioDrain's Streamway System is eco-friendly as it contributes to cleaning up the environment. Currently, approximately 50 million bloody, potentially disease infected, canisters go to landfills annually in the United States. These tainted canisters can remain in landfills for years to come.  With the installation of BioDrain's Streamway system, the number of canisters can be significantly reduced.  BioDrain Medical, Inc. makes the operating room and our environment safer, cleaner, and better.  BioDrain products are currently being represented by independent professional sales representatives that cater to the needs of hospitals and ambulatory surgical centers across the country.  

Forward-looking Statements:

Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the company's business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the company's ability to implement its long range business plan for various applications of its technology; the company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the company's reports filed with the Securities and Exchange Commission. This is not a solicitation to buy or sell securities and does not purport to be an analysis of the Company's financial position. See the Company's most recent Quarterly Report on Form 10-Q and related 8-K filings.

Investor Relations Contact:
Stanley Wunderlich
Consulting for Strategic Growth 1 Ltd.
Tel: 800-625-2236 ext. 7770
Email: [email protected]
 

SOURCE BioDrain Medical, Inc.